Deutsche Bank Cuts DocGo Price Target to $8.20 From $10, Maintains Buy Rating
DocGo Analyst Ratings
Northland Securities Sticks to Their Buy Rating for DocGo (DCGO)
Stifel Nicolaus Remains a Buy on DocGo (DCGO)
Buy Rating Affirmed for DocGo: Strong FY23 Finish and Promising FY24 Outlook Fuel Growth Prospects
Analysts Offer Insights on Healthcare Companies: DocGo (DCGO), Revance Therapeutics (RVNC) and Alector (ALEC)
DocGo Analyst Ratings
Stifel Nicolaus Remains a Buy on DocGo (DCGO)
Analysts' Top Healthcare Picks: CVRx (CVRX), DocGo (DCGO)
Analysts Offer Insights on Healthcare Companies: DocGo (DCGO), SAGE Therapeutics (SAGE) and Globus Medical (GMED)
Buy Rating Reaffirmed for DocGo Amid Short Seller Challenges and Growth Prospects
BTIG Remains a Buy on DocGo (DCGO)
Stifel Nicolaus Keeps Their Buy Rating on DocGo (DCGO)
Analysts Are Bullish on These Healthcare Stocks: Globus Medical (GMED), DocGo (DCGO)
Stifel Nicolaus Remains a Buy on DocGo (DCGO)
Stifel Nicolaus Issues a Buy Rating on DocGo (DCGO)
Northland Securities Keeps Their Buy Rating on DocGo (DCGO)
Analysts' Top Healthcare Picks: DocGo (DCGO), Kezar Life Sciences (KZR)
Analysts Are Bullish on Top Healthcare Stocks: Henry Schein (HSIC), DocGo (DCGO)
Stifel Reiterates Buy on DocGo, Maintains $12 Price Target
No Data